MedTrace Logo

Colonisation Efficacy of Oral Probiotic Fast Melt Powder

NCT05367518 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-05-10

No results posted yet for this study

Summary

To evaluate the colonisation efficacy (i.e. ability of the probiotic bacteria to remain in your mouth) of a fast melt powder that quickly dissolves in the mouth. The fast melt powder will contain a Streptococcus salivarius probiotic and the study is to be done in healthy adults.

Conditions

  • Microbial Colonization

Interventions

DIETARY_SUPPLEMENT

Probiotic Streptococcus salivarius K12 Fast Melt Powder 1 Billion colony forming units /g)

Probiotic Streptococcus salivarius K12 products are commercially available in traditional formats such as chewable tablet (lozenge) for local delivery in the oral cavity to provide oral health benefits. In this study, a Fast Melt Powder formulation will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity.

DIETARY_SUPPLEMENT

Probiotic Streptococcus salivarius K12 Fast Melt Powder 100 Million colony forming units /g)

Probiotic Streptococcus salivarius K12 products are commercially available in traditional formats such as chewable table (lozenges) for local delivery in the oral cavity to provide oral health benefits. In this study, a Fast Melt Powder formulation will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity.

Sponsors & Collaborators

  • BLIS Technologies Limited

    lead INDUSTRY

Principal Investigators

  • John D Hale, PhD · Blis Technologies Ltd, Dunedin, New Zealand

  • John R Tagg, PhD · Blis Technologies Ltd, Dunedin, New Zealand

  • Rohit Jain, PhD · Blis Technologies Ltd, Dunedin, New Zealand

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-15
Primary Completion
2022-05-25
Completion
2022-06-30

Countries

  • New Zealand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05367518 on ClinicalTrials.gov